U.S. approval sought for memantine to slow severe cognitive decline. (New Class of Drugs).: An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on September 15, 2002. The length of the article is 709 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: U.S. approval sought for memantine to slow severe cognitive decline. (New Class of Drugs).
Author: Miriam E. Tucker
Publication:Internal Medicine News (Magazine/Journal)
Date: September 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 18 Page: 5(1)

Distributed by Thomson Gale